Sophia Genetics Earnings & Forecasts

Sophia Genetics (SOPH) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 4, 2026	$-0.30	$-0.22	-36.4 %
Q1	May 5, 2026	$-0.27	$-0.24	-12.5 %
Q4	Mar 3, 2026	$-0.28	$-0.20	-40.0 %
Q3	Nov 4, 2025	$-0.30	$-0.20	-50.0 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 4, 2026	$23.31M	$21.62M	7.84 %
Q1	May 5, 2026	$21.69M	$20.40M	6.29 %
Q4	Mar 3, 2026	$21.71M	$20.89M	3.92 %
Q3	Nov 4, 2025	$19.46M	$18.13M	7.36 %

Sophia Genetics Guidance

Sophia Genetics (SOPH)는 8월 4, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $94M - $96M 범위로 예상했습니다.

이전 가이던스와 비교하여 Sophia Genetics는 매출 전망치를 이전 범위인 상향 조정됨에서 $92M - $94M로 상향 조정했습니다.

Sophia Genetics은 14과 11월 8, 2022 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 7 times and lowered it 1 time, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$-0.22	$-0.24	$-0.20	$-0.20
Actual	$-0.30	$-0.27	$-0.28	$-0.30
Surprise	-36.4%	-12.5%	-40.0%	-50.0%
Revenue
Estimate	$21.6M	$20.4M	$20.9M	$18.1M
Actual	$23.3M	$21.7M	$21.7M	$19.5M
Surprise	+7.84%	+6.29%	+3.92%	+7.36%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$-0.19	$-0.14	$-0.09	$-0.08
Revenue
Consensus	$24.0M	$26.3M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est

Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $92.000 million-$94.000 million to $94.000 million-$96.000 million vs $93.403 million estimate.

Benzinga Newsdesk

PRO
Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 9.09 percent increase over losses of $(0.33) per share from

Benzinga Newsdesk

Stock Market Today: Dow Futures Tumble, S&P 500, Nasdaq Gains As Investors Await FOMC Decision— Amkor, La-Z-Boy In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures were mixed on Wednesday, as the Dow Jones fell, while the Nasdaq 100 and S&P 500 advanced, following Tuesday’s mixed close.

Rishabh Mishra

CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday

U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in focus. La-Z-Boy shares jump 17.7% after earnings.

Avi Kapoor

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Sophia Genetics Affirms FY2026 Sales Guidance of $92.000M-$94.000M vs $93.250M Est

Sophia Genetics (NASDAQ:SOPH) affirms FY2026 sales outlook from $92.000 million-$94.000 million to $92.000 million-$94.000 million vs $93.250 million estimate.

Benzinga Newsdesk

Sophia Genetics SA